Normal view MARC view ISBD view

Visual cliff performance in 10 species of muroid rodents. [electronic resource]

By:

Sloane, S A

Contributor(s):

Producer: 19781025Description: 244-8 p. digitalISSN:

0090-4996

Subject(s):

Online resources:

Available from publisher's website

In: Animal learning & behavior vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

There are no comments on this title.

to post a comment.

Back to results

61 In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
by Ungerstedt, J
62 Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.
by Huang, Wei-Jan
63 The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo.
by Chao, Min-Wu
64 Measuring the Effect of Histone Deacetylase Inhibitors (HDACi) on the Secretion and Activity of Alpha-1 Antitrypsin.
by Wang, Chao
65 A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
by Puduvalli, Vinay K
66 The search for an HIV cure: tackling latent infection.
by Kent, Stephen J
67 Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
by Marfurt, Jutta
68 A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum.
by Parise, Robert A
69 HIV: Shock and kill.
by Deeks, Steven G
70 The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ.
by Hashioka, Sadayuki
71 Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat.
by Afifi, Salma
72 The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.
by Choi, Sun Ea
73 Histone deacetylase inhibitors: a review on class-I specific inhibition.
by Behera, Jagannath
74 A phase 2 study of vorinostat in acute myeloid leukemia.
by Schaefer, Eric W
75 Histone deacetylase inhibitor for NUT midline carcinoma.
by Maher, Ossama M
76 [Histone deacetylase inhibitors as a new generation of anti-cancer agents].
by Stepulak, Andrzej
77 Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
by Iyer, Abishek
78 Serine proteases in histone deacetylase inhibitor-induced apoptosis.
by Sonnemann, Jürgen
79 Involvement of ALAD-20S Proteasome Complexes in Ubiquitination and Acetylation of Proteasomal α2 Subunits.
by Schmitt, Sara M
80 Development of lipid nanoparticles for a histone deacetylases inhibitor as a promising anticancer therapeutic.
by Tran, Tuan Hiep